Get the Stockscreener App
0.7739
9.15%
0.0649
After Hours:
.77
-0.0039
-0.50%
Lexaria Bioscience Corp Stock (LEXX) Forecast
The Lexaria Bioscience Corp (LEXX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.5189, representing a +96.26% increase from the current price of $0.7739. The highest analyst price target is $1.9357, and the lowest is $1.1021.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LEXX Price Target
Average 1.4679
(+89.68% Upside)
Is Lexaria Bioscience Corp (LEXX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 58.90 | Neutral |
| STOCH(9,6) | 82.29 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.0046 | Buy |
| ADX(14) | 8.3747 | Neutral |
| William %R | -4.2469 | Sell |
| CCI(14) | 117.60 | Buy |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.6895
Buy
|
0.7025
Buy
|
| MA20 |
0.6752
Buy
|
0.6986
Buy
|
| MA50 |
0.7009
Buy
|
0.7425
Buy
|
| MA100 |
0.853
Sell
|
0.8235
Sell
|
| MA200 |
0.9092
Sell
|
1.0207
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, LEXX could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 7 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on LEXX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 58.9 indicates that LEXX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 82.29 indicates that LEXX is oversold. This means that LEXX price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that LEXX is oversold. This suggests that LEXX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 8.3747 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 117.6 indicates that LEXX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term LEXX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lexaria Bioscience Corp financial reports and earnings history, Lexaria Bioscience Corp (LEXX) stock could reach $1.2027 by 2030, $3.4756 by 2040 and $3.0707 by 2050. See the projected annual prices until 2050 of the Lexaria Bioscience Corp stock below:
- Lexaria Bioscience Corp (LEXX) is expected to reach an average price of $0.596 in 2035, with a high prediction of $0.5624 and a low estimate of $0.4681. This indicates an $-22.99% rise from the last recorded price of $0.7739.
- Lexaria Bioscience Corp (LEXX) stock is projected to chart a bullish course in 2040, with an average price target of $2.6879, representing an $247.32% surge from its current level. The forecast ranges from a conservative $2.212 to a sky-high $3.4756.
- Our analysts predict Lexaria Bioscience Corp (LEXX) to jump 133.37% by 2045, soaring from $2.0503 to an average price of $1.8061, potentially reaching $1.8968. While $2.0503 is the low estimate, the potential upside is significant.
- Lexaria Bioscience Corp (LEXX) stock is expected to climb by 2050, reaching an average of $3.2407, a $318.74% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.0707 and $3.0657, respectively, highlighting the market's uncertainty.
Lexaria Bioscience Corp Stock (LEXX) Year by Year Forecast
Lexaria Bioscience Corp Stock (LEXX) Price Forecast for 2026
The predicted value for Lexaria Bioscience Corp (LEXX) in 2026 is set at an average of $1.4687. Estimates vary from a peak of $2.9152 to a trough of $0.0222, indicating an +89.78% surge from the present price of $0.7739.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $1.5335 | $1.1021 | $1.9357 | +98.15% |
| May, 2026 | $1.5064 | $1.4057 | $1.7557 | +94.65% |
| June, 2026 | $2.2392 | $1.4972 | $2.4285 | +189.34% |
| July, 2026 | $2.0828 | $1.5614 | $2.3099 | +169.13% |
| August, 2026 | $2.3256 | $2.0135 | $2.6149 | +200.51% |
| September, 2026 | $2.4492 | $1.9964 | $2.5678 | +216.48% |
| October, 2026 | $2.0421 | $1.6794 | $2.9152 | +163.87% |
| November, 2026 | $1.4149 | $1.385 | $2.1028 | +82.83% |
| December, 2026 | $0.0713 | $0.0222 | $1.4156 | -90.79% |
Lexaria Bioscience Corp Stock (LEXX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lexaria Bioscience Corp (LEXX) is $3.1167, with a high forecast of $6.2128 and a low forecast of $0.0206. This indicates an +302.72% increase from the last price of $0.7739.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1218 | $0.0206 | $0.1714 | -84.27% |
| February, 2027 | $0.1989 | $0.0379 | $0.2842 | -74.30% |
| March, 2027 | $0.3678 | $0.0947 | $0.5349 | -52.48% |
| April, 2027 | $0.2307 | $0.1846 | $0.4892 | -70.19% |
| May, 2027 | $0.3348 | $0.1913 | $0.3535 | -56.74% |
| June, 2027 | $0.8071 | $0.1942 | $1.0771 | +4.28% |
| July, 2027 | $0.8499 | $0.5492 | $1.1599 | +9.82% |
| August, 2027 | $0.6428 | $0.5829 | $1.0506 | -16.95% |
| September, 2027 | $0.7763 | $0.5542 | $1.0356 | +0.31% |
| October, 2027 | $1.4992 | $0.777 | $2.1392 | +93.72% |
| November, 2027 | $4.862 | $1.4199 | $5.372 | +528.25% |
| December, 2027 | $1.4856 | $1.4856 | $6.2128 | +91.96% |
Lexaria Bioscience Corp Stock (LEXX) Price Forecast for 2028
In 2028, Lexaria Bioscience Corp (LEXX) is projected to reach an average price of $6.1081, with a high projection of $11.00 and a low estimate of $1.2163. This indicates an +689.27% rise from the last price of $0.7739.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.1324 | $1.2163 | $3.0485 | +175.54% |
| February, 2028 | $5.4343 | $2.57 | $7.9243 | +602.19% |
| March, 2028 | $4.5114 | $3.2697 | $6.1107 | +482.95% |
| April, 2028 | $3.9571 | $3.5043 | $4.7399 | +411.32% |
| May, 2028 | $4.6743 | $2.98 | $7.3328 | +503.99% |
| June, 2028 | $5.04 | $3.7757 | $5.69 | +551.24% |
| July, 2028 | $5.3657 | $4.9428 | $5.9314 | +593.33% |
| August, 2028 | $4.6628 | $4.4528 | $11.00 | +502.51% |
| September, 2028 | $4.7285 | $3.7957 | $5.0271 | +511.00% |
| October, 2028 | $5.3742 | $4.4428 | $5.7114 | +594.44% |
| November, 2028 | $5.1224 | $4.6685 | $5.67 | +561.89% |
| December, 2028 | $4.0971 | $4.0771 | $5.3528 | +429.41% |
Lexaria Bioscience Corp Stock (LEXX) Price Forecast for 2029
The 2029 price forecast for Lexaria Bioscience Corp Stock (LEXX) is $2.5321 on average, with a high prediction of $4.6428 and a low estimate of $0.4213. This represents an +227.18% increase from the previous price of $0.7739.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.9542 | $2.7142 | $4.6428 | +281.73% |
| February, 2029 | $3.1499 | $2.3161 | $3.3199 | +307.02% |
| March, 2029 | $2.4756 | $2.2656 | $3.4814 | +219.89% |
| April, 2029 | $2.1014 | $1.7699 | $2.5269 | +171.53% |
| May, 2029 | $1.8585 | $1.1971 | $2.2933 | +140.15% |
| June, 2029 | $1.5642 | $1.5042 | $3.3928 | +102.12% |
| July, 2029 | $0.5799 | $0.4885 | $1.7056 | -25.07% |
| August, 2029 | $0.9071 | $0.4213 | $1.0756 | +17.21% |
| September, 2029 | $1.5028 | $1.1985 | $2.0699 | +94.18% |
| October, 2029 | $1.8699 | $1.187 | $2.0187 | +141.62% |
| November, 2029 | $1.5806 | $1.3028 | $2.1913 | +104.24% |
| December, 2029 | $1.0513 | $0.8026 | $1.847 | +35.85% |
Lexaria Bioscience Corp Stock (LEXX) Price Forecast for 2030
Lexaria Bioscience Corp Stock (LEXX) is expected to reach an average price of $1.1869 in 2030, with a high forecast of $2.2352 and a low forecast of $0.1387. This signifies an +53.37% surge from the last price of $0.7739.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.8185 | $0.4042 | $1.2027 | +5.76% |
| February, 2030 | $0.9842 | $0.7113 | $1.0613 | +27.17% |
| March, 2030 | $1.2999 | $0.9856 | $1.737 | +67.96% |
| April, 2030 | $1.3956 | $0.8727 | $1.4056 | +80.33% |
| May, 2030 | $1.4427 | $1.3127 | $1.9299 | +86.42% |
| June, 2030 | $1.7684 | $1.3342 | $1.8856 | +128.51% |
| July, 2030 | $1.0156 | $0.9557 | $2.2352 | +31.23% |
| August, 2030 | $0.0387 | $0.1387 | $1.047 | -95.00% |
| September, 2030 | $0.6002 | $0.623 | $0.5431 | -22.44% |
| October, 2030 | $0.6056 | $0.6102 | $0.5787 | -21.75% |
| November, 2030 | $0.5203 | $0.5704 | $0.5348 | -32.77% |
| December, 2030 | $0.2945 | $0.3345 | $0.4287 | -61.95% |
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):